USE OF LEFT-VENTRICULAR EJECTION FRACTION OR WALL-MOTION SCORE INDEX IN PREDICTING ARRHYTHMIC DEATH IN PATIENTS FOLLOWING AN ACUTE MYOCARDIAL-INFARCTION
L. Kober et al., USE OF LEFT-VENTRICULAR EJECTION FRACTION OR WALL-MOTION SCORE INDEX IN PREDICTING ARRHYTHMIC DEATH IN PATIENTS FOLLOWING AN ACUTE MYOCARDIAL-INFARCTION, PACE, 20(10), 1997, pp. 2553-2559
All-cause mortality and morbidity following an acute myocardial infarc
tion (AMI) are correlated to LV systolic dysfunction. The correlation
is closest with mortality and morbidity associated with congestive hea
rt failure (CHF). Prediction of arrhythmic death in patients with AMI
relies on the correlation between arrhythmic death and ''sudden unexpe
cted death'' defined as death within 1 hour of onset of new symptoms.
Assessment of late potentials, heart rate variability (HRV), T wave al
ternans, arrhythmias seen on Holter monitoring or during exercise test
ing electrophysiological testing, and baroreceptor assessment have all
proven to be useful in the prediction of sudden death even when LV sy
stolic function is known. In selected populations HRV is superior to L
V systolic function assessment in predicting sudden death and/or arrhy
thmic events, and may even predict ah-cause mortality with the same pr
ecision. Comparisons of other methods with LV function assessment shou
ld be interpreted with care because most methods have been evaluated i
n subgroups of infarct patients with a low risk of death. Results from
a large series of high risk patients with AMI (the TRAndolapril Cardi
ac Evaluation study) have shown that even in patients with severe depr
essed LV systolic function around one-third of the patients will die s
uddenly. The current situation is that LV function appears to be the b
est method of predicting death whereas other methods appear very promi
sing for detecting arrhythmic death in more selected populations. The
optimal method for selecting patients at high risk of arrhythmic death
has not yet been developed, but a combination of LV function and anot
her method, i.e., HRV, appears promising. This may ensure that the enr
olled patients have an increased risk of death and that this risk will
be due to arrhythmic events. Patients with LVEF of 10% or less can be
excluded as they will most likely not die suddenly.